Targeted therapy for central nervous system : formulation, clinical challenges, and regulatory strategies /

This book, 'Targeted Therapy for the Central Nervous System', provides an in-depth exploration of the formulation and clinical challenges associated with developing targeted therapies for central nervous system (CNS) disorders. Edited by experts in the field from various prestigious instit...

Full description

Bibliographic Details
Corporate Author:	ScienceDirect (Online service)
Other Authors:	Patel, Viral (Editor), Singh Rajput, Mithun (Editor), Shah, Jigna Samir (Editor), Mehta, Tejal (Editor)
Format:	eBook
Language:	English
Published:	London, United Kingdom : Academic Press, [2025]
Subjects:	Central nervous system > Diseases > Chemotherapy. Drug targeting. Drug delivery systems. Drug Delivery Systems Système nerveux central > Maladies > Chimiothérapie. Médicaments > Ciblage. Systèmes d'administration de médicaments. Electronic books.
Online Access:	Connect to the full text of this electronic book

Table of Contents:

Chapter 1. Etiology and treatment challenges for neurodegenerative disorders
Chapter 2. Etiology and treatment challenges for neurotraumatic and psychiatric disorders
Chapter 3. Barriers to progress of neurotherapeutics: Getting drugs to the brain
Chapter 4. IGF-II conjugated nanocarrier for brain targeting
Chapter 5. ApoE potential in CNS drugs targeting and as CNS therapeutic
Chapter 6. Transferrin functionalized nanoparticles for targeted drug delivery in biological systems
Chapter 7. Surface engineered multimodal magnetic nanoparticles for neurodegenerative diseases
Chapter 8. Tau targeting biomimetic nanoparticles
Chapter 9. Stem cell therapy as a novel concept to combat CNS disorders
Chapter 10. SR-B1 receptor targeting in CNS disorders
Chapter 11. [Beta]- and [gamma]-secretases as therapeutic targets for Alzheimer's disease
Chapter 12. Minimally invasive nasal depot (MIND) technique for direct BDNF AntagoNAT delivery to the brain
Chapter 13. Immunosuppressive and immunomodulatory therapies
Chapter 14. CRISPR/Cas9 gene editing: A new hope for Alzheimer's disease
Chapter 15. Artificial intelligence: Ways and means for central nervous system (CNS) delivery
Chapter 16. Carbon dots as versatile nano-architectures for the treatment of neurological disorders
Chapter 17. Animal models for clinical evaluation
Chapter 18. Medical device: Development of next-generation devices from an engineering perspective
Chapter 19. Regulation of nanomaterials and nanomedicines for clinical applications
Chapter 20. Regulatory considerations for the use of biomarkers and personalized medicine in CNS drug development
Chapter 21. Regulatory toxicology testing for pharmaceuticals
Chapter 22. Emerging challenges and opportunities for drug and drug product registrations
Chapter 23. CRISPR/Cas9 gene editing: A new hope for Parkinson's disease.